Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed + Oxaliplatin in Advanced Gastric Carcinoma
NCT00192088Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in Gastric carcinoma (GC), sponsored by Eli Lilly and Company. Started May 2004; status: completed.
02
Drugs
pemetrexed
03
Conditions
Gastric carcinoma (GC)
Beyond the preview
Go deeper on NCT00192088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192088.